Summary Stage 2018: Gallbladder

Summary Stage 2018

Notes

**Gallbladder** C239 C239 Gallbladder **Note:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 24 *Gallbladder*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.

NAACCR Item

NAACCR #764
SS2018 Description
0 In situ: noninvasive, intraepithelial
1 Localized only (localized, NOS) - Confined to gallbladder, NOS - Lamina propria - Mucosa, NOS - Muscularis propria (layer) - Submucosa (superficial invasion)
2 Regional by direct extension only - Ampulla of Vater - Branch(es) of hepatic artery (right or left) - Branch(es) of portal vein (right or left) - Duodenum - Extrahepatic bile duct(s) - Liver, less than or equal to 2 cm OR distance not stated - Omentum (greater, lesser, NOS) - Pancreas - Perimuscular connective tissue (peritoneal and hepatic side) - Serosa (visceral peritoneum) - Small intestine, NOS
3 Regional lymph node(s) involved only - Celiac artery - Cystic duct (Calot’s node) - Hepatic artery - Node of foramen of Winslow (omental) (epiploic) - Pancreaticoduodenal - Pericholedochal (common bile duct) - Periduodenal - Peripancreatic (near head of pancreas only) - Porta hepatis (portal) (periportal) (hilar) (in hilus of liver) - Portal vein - Retroperitoneal, NOS - Superior mesenteric - Regional lymph node(s), NOS + Lymph node(s), NOS
4 Regional by BOTH direct extension AND regional lymph node(s) involved - Codes (2) + (3)
7 Distant site(s)/lymph node(s) involved - Distant site(s) (including further contiguous extension) + Abdominal wall + Colon + Cystic artery/vein + Diaphragm + Hepatic artery (common, NOS) + Liver, greater than 2 cm + Portal vein (main, NOS) + Stomach + Two or more extrahepatic organs or structures - Distant lymph node(s), NOS + Para-aortic + Pericaval + Peripancreatic (along body and tail of pancreas only) - Distant metastasis, NOS + Carcinomatosis + Distant metastasis WITH or WITHOUT distant lymph node(s)
9 Unknown if extension or metastasis
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) Zhu, A.X., Pawlik, T.M., Vauthey, J.N., et al. **Gallbladder**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 303-309